BrainsWay Financials
| BRSYF Stock | USD 8.53 0.00 0.00% |
BrainsWay |
Understanding current and past BrainsWay Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BrainsWay's financial statements are interrelated, with each one affecting the others. For example, an increase in BrainsWay's assets may result in an increase in income on the income statement.
BrainsWay Stock Summary
BrainsWay competes with Bone Biologics, BICO Group, Aurora Spine, and Tenon Medical. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Bynet Building, Jerusalem, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.brainsway.com |
| Phone | 972 2 582 4030 |
| Currency | USD - US Dollar |
BrainsWay Key Financial Ratios
There are many critical financial ratios that BrainsWay's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BrainsWay reports annually and quarterly.| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 | |||
| Target Price | 10.75 | |||
| Number Of Employees | 118 | |||
| Beta | 0.2 |
BrainsWay Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BrainsWay's current stock value. Our valuation model uses many indicators to compare BrainsWay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BrainsWay competition to find correlations between indicators driving BrainsWay's intrinsic value. More Info.BrainsWay is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BrainsWay's earnings, one of the primary drivers of an investment's value.BrainsWay Systematic Risk
BrainsWay's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BrainsWay volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on BrainsWay correlated with the market. If Beta is less than 0 BrainsWay generally moves in the opposite direction as compared to the market. If BrainsWay Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BrainsWay is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BrainsWay is generally in the same direction as the market. If Beta > 1 BrainsWay moves generally in the same direction as, but more than the movement of the benchmark.
BrainsWay December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BrainsWay help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BrainsWay. We use our internally-developed statistical techniques to arrive at the intrinsic value of BrainsWay based on widely used predictive technical indicators. In general, we focus on analyzing BrainsWay Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BrainsWay's daily price indicators and compare them against related drivers.
| Information Ratio | 0.121 | |||
| Maximum Drawdown | 170.79 |
Complementary Tools for BrainsWay Pink Sheet analysis
When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |